Holding(s) in Company Replacement

For filings with the FSA include the annex

For filings with issuer exclude the annex 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

BIOFUTURES INTERNATIONAL PLC

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

YES

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

An event changing the breakdown of voting rights

Other (please specify):______________

3. Full name of person(s) subject to notification obligation:

Stoutman Holdings LTD

4. Full name of shareholder(s) (if different from 3):

5. Date of transaction (and date on which the threshold is crossed or reached if different):

8 April 2009

6. Date on which issuer notified:

30 April 2009

7. Threshold(s) that is/are crossed or reached:

3%

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

Direct

Indirect

Direct

Indirect

GB00B12B4T47

22,068,380

22,068,380

22,068,380

22,068,380

N/A

14.6%

N/A

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

N/A

N/A

N/A

N/A

N/A

Total (A+B)

Number of voting rights

Percentage of voting rights

22,068,380

14.6%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

Stoutman Holdings LTD is a investment holding company

Proxy Voting:

10. Name of proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:

14 Contact name:

15. Contact telephone number:

C: Additional information

For further information please contact:

Julie Pomeroy, Finance Director,

Biofutures International Plc 07936 848343

Derek Crowhurst, 

Blomfield Corporate Finance 020 7489 4500

Colin Rowbury, 

Religare Hichens, Harrison 020 7382 7771